Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2025-12-25 @ 11:16 PM
Study NCT ID:
NCT05335993
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-10
First Post:
2022-02-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
Sponsor:
CanariaBio Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-10
First Submit QC Date:
None
Study First Post Date:
2022-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-07
Last Update Post Date:
2025-07-10
Last Update Post Date Type:
ACTUAL